NCT04824443

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

Exercise Therapy in Cancer Patients Hospitalized for COVID-19: A Digitized Clinical Trial

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to evaluate the safety and tolerability of a 30-week aerobic exercise therapy program in cancer patients recovering from COVID-19. The study will look at whether the aerobic exercise therapy causes few or mild side effects in participants. Aerobic exercise is physical activity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for several minutes at a time. The aerobic exercise therapy being used in this study will be a walking program that will be adjusted so it matches participant fitness levels (how much exercise you can handle).

Conditions

• Covid19
• Coronavirus
• Cancer

Interventions

Type	Name	Description
OTHER	Aerobic Exercise Therapy	Aerobic Exercise Therapy/AT will consist of 30 weeks of treadmill walking sessions. AT will consist of supervised, individualized walking delivered up to 6 times weekly (over a 7-day period) to achieve a cumulative total duration ranging from 90 mins/wk up to 375 mins/wk following a non-linear dosing schedule. The planned dose and scheduling of AT will be continually altered and progressed in conjunction with appropriate rest/recovery sessions across the entire intervention period (i.e., non-linear periodized schedule).

Timeline

• Start date: 2021-03-29
• Primary completion: 2025-10-24
• Completion: 2025-10-24
• First posted: 2021-04-01
• Last updated: 2025-10-27

Locations

7 sites across 1 country: United States